C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 38,726 shares at $49.29 ($1.9M) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Scheduled sale ($1.9M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.64 | 6,500 | $323K | 16.9% |
| 2 | $49.29 | 16,113 | $794K | 41.6% |
| 3 | $49.29 | 16,113 | $794K | 41.6% |
| Total | $49.35 avg | 38,726 | $1.9M | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |